Naoki Tohdoh

Title: Naoki Tohdoh: Innovator in Gene Therapy

Introduction

Naoki Tohdoh is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of gene therapy, particularly through his work on adenovirus vectors. With a total of 4 patents, Tohdoh's innovations are paving the way for advancements in medical treatments.

Latest Patents

One of Tohdoh's latest patents is a recombinant adenovirus vector designed to reduce side effects during in vivo administration. This novel vector alleviates inflammation by inhibiting the expression of an adenovirus gene through a foreign promoter inserted into the adenovirus genome. Additionally, he has developed methods for producing this vector, as well as a cell line for its production and a gene therapy method utilizing the recombinant adenovirus vector.

Career Highlights

Throughout his career, Naoki Tohdoh has worked with notable companies such as Sumitomo Pharmaceuticals Company Limited and Dainippon Sumitomo Pharma Co., Ltd. His expertise in the field has allowed him to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Tohdoh has collaborated with esteemed colleagues, including Michio Nakai and Kazuo Komiya. These partnerships have further enhanced his research and innovation in gene therapy.

Conclusion

Naoki Tohdoh's work in developing recombinant adenovirus vectors represents a significant step forward in gene therapy. His contributions are vital for the future of medical treatments, showcasing the importance of innovation in healthcare.